**Core Concept:** Safe muscle relaxants in patients with renal failure are drugs with minimal excretion through the kidneys, reducing the risk of accumulation and potential toxicity.

**Why the Correct Answer is Right:**
The correct answer, **D:** **Propofol**, is a safe muscle relaxant in patients with renal failure because it is a water-soluble drug that is not extensively filtered by the kidneys. Propofol is primarily eliminated through hepatic pathways and does not contribute to the risk of renal toxicity.

**Why Each Wrong Option is Incorrect:**
A. **Phenytoin (Option A)** is a hydroscopic drug that is extensively filtered by the kidneys, increasing the risk of accumulation and toxicity in renal failure patients.

B. **Midazolam (Option B)** is another water-soluble drug, but it is also extensively filtered by the kidneys, making it less preferable compared to propofol.

C. **Thiopental (Option C)** is a lipid-soluble drug, similar to propofol, but its use may lead to higher risks due to its extensive filtration in renal failure patients.

E. **Propofol (Option D)** is the appropriate choice because it is water-soluble and primarily eliminated through hepatic pathways, reducing the risk of renal toxicity.

**Clinical Pearl:** In renal failure patients, it is essential to consider the pharmacokinetic properties of drugs to prevent accumulation and associated toxicities. Choosing propofol as a muscle relaxant due to its minimal renal elimination ensures safer drug administration in compromised renal function.